بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
small decrease » small increased (توسيع البحث)
all decrease » a decrease (توسيع البحث), fold decrease (توسيع البحث), awd decreased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
small decrease » small increased (توسيع البحث)
all decrease » a decrease (توسيع البحث), fold decrease (توسيع البحث), awd decreased (توسيع البحث)
-
601
<i>Kif15</i> deficient mice exhibit both depressive and manic behaviors in adulthood.
منشور في 2025الموضوعات: -
602
<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus.
منشور في 2025الموضوعات: -
603
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
-
604
-
605
-
606
-
607
-
608
-
609
-
610
-
611
-
612
-
613
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
-
614
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
-
615
-
616
-
617
-
618
-
619
-
620